Halozyme Therapeutics
HALO
#1998
Rank
โ‚น670.99 B
Marketcap
โ‚น5,432
Share price
-1.44%
Change (1 day)
59.97%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): โ‚น142.84

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น148.72. In 2022 the company made an earnings per share (EPS) of โ‚น126.50 a decrease over its 2021 EPS that were of โ‚น243.60.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น142.8412.92%
2022โ‚น126.50-48.07%
2021โ‚น243.60196.88%
2020โ‚น82.05-292%
2019-โ‚น42.74-9.09%
2018-โ‚น47.01-237.5%
2017โ‚น34.19-149.38%
2016-โ‚น69.23211.54%
2015-โ‚น22.22-52.73%
2014-โ‚น47.01-24.66%
2013-โ‚น62.3948.98%
2012-โ‚น41.88145%
2011-โ‚น17.09-64.29%
2010-โ‚น47.86-17.65%
2009-โ‚น58.129.68%
2008-โ‚น52.9993.75%
2007-โ‚น27.3533.33%
2006-โ‚น20.51-4%
2005-โ‚น21.37-3.85%
2004-โ‚น22.22-13.33%
2003-โ‚น25.6483.59%
2002-โ‚น13.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น16.24-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น464.05 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น437.62 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น158.98 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น271.82 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1,204 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA